Abzena
Abzena is a leading end-to-end bioconjugate and complex biologics contract development and manufacturing organisation (CDMO) and contract research organisation (CRO).
Description
Abzena is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO), offering comprehensive services for biologics, bioconjugates, and antibody-drug conjugates (ADCs). Their expertise spans drug discovery, development, and GMP manufacturing, supporting the entire lifecycle of drug products from early discovery to commercialisation.
Key Products and Services
- Antibody discovery and development
- Bioconjugate and ADC design, development, and manufacturing
- Cell line development and process development
- Immunogenicity testing with EpiScreen® 2.0
- Complex chemistry, including payload and linker design
- GMP manufacturing for clinical and commercial stages
Abzena is committed to advancing complex biologics and helping clients deliver life-changing therapies to the market. Through integrated, high-quality services, they provide tailored solutions that accelerate drug development timelines.